2. Efficacy and safety analysis of AcoStream thrombus aspiration device in the treatment of acute superior mesenteric artery embolism

Study Overview
Patients: 10 (mean age: 77.6 years)
Condition: Acute superior mesenteric artery embolism (ASMAE)
Procedure: Percutaneous mechanical thrombectomy (PMT) using AcoStream™
Timeframe: December 2022 – December 2023

Key Findings
✅ 100% surgical success rate with no perioperative complications.
✅ 8/10 patients had complete symptom relief with successful thrombus removal.
✅ 2/10 patients required necrotic bowel resection due to delayed treatment.
✅ Follow-up (8.8 months avg.): No signs of recurrence or further complications.

Clinical Advantages of AcoStream™
Minimally invasive – Avoids high-risk open surgery.
Effective clot removal – High success in clearing mesenteric artery thrombi.
Safe for critical vascular interventions – No major bleeding or vascular injury reported.

Conclusion
AcoStream™ has proven to be a safe and effective PMT device for ASMAE, offering a promising alternative to conventional open surgery and other thrombectomy devices. It provides quick revascularization, minimal complications, and a faster recovery path, making it an ideal solution for interventional vascular procedures.